Jefferies Financial Group
CHRS icon

Jefferies Financial Group’s Coherus Oncology CHRS Stock Holding History

Jefferies Financial Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-252,000
Closed -$353K – 1394
2026
Q2 		$353K Hold
252,000
– – ﹤0.01% 1339
2026
Q1 		$426K Sell
252,000
-143,190
-36% -$254K ﹤0.01% 1273
2025
Q4 		$561K Buy
395,190
+69,565
+21% +$101K ﹤0.01% 1301
2025
Q3 		$534K Buy
325,625
+8,000
+3% +$8.9K ﹤0.01% 1062
2025
Q2 		$232K Hold
317,625
– – ﹤0.01% 1092
2025
Q1 		$256K Buy
317,625
+10,000
+3% +$11.5K ﹤0.01% 1297
2024
Q4 		$425K Buy
307,625
+25,000
+9% +$28K ﹤0.01% 1157
2024
Q3 		$294K Buy
282,625
+86,000
+44% +$118K ﹤0.01% 1121
2024
Q2 		$340K Hold
196,625
– – ﹤0.01% 1081
2024
Q1 		$470K Buy
196,625
+113,000
+135% +$278K ﹤0.01% 1077
2023
Q4 		$278K Buy
83,625
+43,000
+106% +$115K ﹤0.01% 1386
2023
Q3 		$152K Buy
+40,625
New +$188K ﹤0.01% 1393
2023
Q2 		– Sell
-130,625
Closed -$893K – 1720
2023
Q1 		$893K Buy
130,625
+106,000
+430% +$823K 0.01% 934
2022
Q4 		$195K Buy
+24,625
New +$189K ﹤0.01% 1303

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Panagora Asset Management
Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Jefferies Financial Group's CHRS Position: Q3 2026 in Review

Jefferies Financial Group sold out of Coherus Oncology (CHRS) in Q3 2026, closing a stake of 252,000 shares — an estimated $353K sold.

Jefferies Financial Group first reported a position in CHRS in Q4 2022 and held it in 14 quarters. The position peaked at $893K in Q1 2023. 75 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Jefferies Financial Group reported no remaining Coherus Oncology position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 252,000 Coherus Oncology shares in Q3 2026, an estimated $353K.
  • Jefferies Financial Group first reported a position in Coherus Oncology in Q4 2022 and held it in 14 quarters.
  • Jefferies Financial Group's Coherus Oncology position peaked at $893K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.